Rivio raises a R$180M Series A extension as Brazil's top hospitals hand AI the billing

Founded in 2025, already working with 13 hospital groups, and valued at above R$1 billion (about US$200M). Rivio, a São Paulo revenue cycle AI company, announced on 4 November that it had extended its Series A, with Valor Capital Group leading and Monashees, Positive Ventures and APL joining, according to The SaaS News.

The numbers, and why they differ

Rivio's own note puts the extension at R$180M, roughly US$33M, and The SaaS News also reports a US$33M extension. RevCycleAI flags that the sources diverge: Brazilian business daily Valor reports the new money as R$80M, on top of R$100M raised last year. Rivio also says its valuation passed R$500M last December, so it has roughly doubled in under a year. Revenue and use of proceeds haven't been disclosed.

Get Digital Health every TuesdayThree-minute read. Free. One-click unsubscribe.

What it does

Rivio uses AI agents to review claims and flag inconsistencies that cause billing losses or late payment from health plans, with healthcare specialists running the operation. The commercial model stands out: Rivio works alongside each hospital, takes responsibility for the result, guarantees payment from health plans for services and ties its fee to the outcome.

The customer list is a who's who of Brazilian private healthcare, including Hospital Israelita Albert Einstein, Hospital Sírio-Libanês, Hospital Alemão Oswaldo Cruz, A.C.Camargo Cancer Center, Hcor, Hospital São Camilo and AACD.

"Brazil operates on patients with robots and runs hospitals on spreadsheets." Silvio Frison, co-founder and CEO, Rivio

Who's behind it

Frison was previously CEO of Serasa Consumidor. Co-founder Ricardo Sales co-founded education fintech isaac, which Arco Educação acquired for US$150M. A nine-person advisory board includes executives from Einstein, Sírio-Libanês and Oswaldo Cruz. Revenue cycle is the first product, and the company wants to stretch the same model into staffing, beds and supplies.

The bigger picture

Most of what we cover in this newsletter is US revenue cycle AI. Rivio is a useful reminder that the problem is universal wherever private payers and hospitals argue over claims, and that outcome-based pricing is spreading as a sales model. For US vendors eyeing Latin America, there's now a well-funded local operator with blue-chip hospital references.

What it means for hiring

Outcome-based contracts need people who can run the work, not just sell software. We'd expect Rivio and similar firms to hire hospital billing specialists and operations leads alongside engineers.
Moving from revenue cycle into staffing, beds and supplies means new buyers inside the hospital. Product leaders with hospital operations backgrounds become important as the platform widens.
For international health-AI vendors, a funded regional player raises the bar on local presence. In-country commercial leadership in Latin America looks like a growing need.

Share Ask Issy about this →